Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

15.2K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
15.2K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

2.3K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.3K
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

10.1K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
10.1K
Coagulation01:09

Coagulation

11.9K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
11.9K
Coagulation01:06

Coagulation

1.6K
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
1.6K
Structure and Function of Platelets01:18

Structure and Function of Platelets

4.6K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
4.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Electrospun bioactive polymer biomaterials enriched with collagen and platelet-rich plasma as a platform for <i>in vitro</i> chondrogenic differentiation of human mesenchymal stem cells.

Frontiers in bioengineering and biotechnology·2026
Same author

Gene expression, purification, and functional characterization of recombinant conotoxin μ-TIIIA and TIIIAlaMut in <i>Escherichia coli</i> with clinical evaluation of antiwrinkle efficacy.

Biotechnologia·2026
Same author

Modeling and experimental verification of polycaprolactone nanoparticle precipitation.

Scientific reports·2026
Same author

Electrospun bioactive polymer biomaterials enriched with collagen and platelet-rich plasma as a platform for <i>in vitro</i> chondrogenic differentiation of human mesenchymal stem cells.

Frontiers in bioengineering and biotechnology·2025
Same author

Biodistribution of Polyaldehydedextran Nanoparticle-Encapsulated Epirubicin in Ovarian Tumor-Bearing Mice via Optical Imaging.

International journal of molecular sciences·2025
Same author

Antimicrobial Macrocycles - Synthesis, Characterization, and Activity Comparison with Their Linear Polycationic Analogues.

Biomacromolecules·2024

Related Experiment Video

Updated: Mar 26, 2026

Helical Organization of Blood Coagulation Factor VIII on Lipid Nanotubes
12:24

Helical Organization of Blood Coagulation Factor VIII on Lipid Nanotubes

Published on: June 3, 2014

12.8K

The factor VIII protein and its function.

Anna Mazurkiewicz-Pisarek1, Grażyna Płucienniczak1, Tomasz Ciach2

  • 1Institute of Biotechnology and Antibiotics, Bioengineering Department, Warszawa, Poland.

Acta Biochimica Polonica
|January 30, 2016
PubMed
Summary

Factor VIII (FVIII) is crucial for blood clotting by enhancing factor IXa activity. Genetic variants in FVIII can cause severe bleeding disorders, highlighting its importance in hemostasis.

More Related Videos

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

19.5K
Author Spotlight: High-Sensitivity Tissue Factor Activity Assay for Plasma Diagnosis
03:53

Author Spotlight: High-Sensitivity Tissue Factor Activity Assay for Plasma Diagnosis

Published on: December 29, 2023

1.4K

Related Experiment Videos

Last Updated: Mar 26, 2026

Helical Organization of Blood Coagulation Factor VIII on Lipid Nanotubes
12:24

Helical Organization of Blood Coagulation Factor VIII on Lipid Nanotubes

Published on: June 3, 2014

12.8K
Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

19.5K
Author Spotlight: High-Sensitivity Tissue Factor Activity Assay for Plasma Diagnosis
03:53

Author Spotlight: High-Sensitivity Tissue Factor Activity Assay for Plasma Diagnosis

Published on: December 29, 2023

1.4K

Area of Science:

  • Biochemistry
  • Hematology
  • Molecular Biology

Background:

  • Factor VIII (FVIII) is an essential protein in the blood coagulation cascade.
  • It is synthesized as a single chain of approximately 300 kDa and processed into heavy (200 kDa) and light (80 kDa) chains.
  • FVIII plays a critical role in hemostasis by increasing the catalytic efficiency of factor IXa.

Purpose of the Study:

  • To elucidate the structure and function of Factor VIII.
  • To understand the molecular basis of Factor VIII's role in coagulation.
  • To highlight the implications of Factor VIII variants in bleeding disorders.

Main Methods:

  • Structural analysis of Factor VIII domains (A1-A2-B-A3-C1-C2).
  • Biochemical assays to determine Factor VIII's catalytic enhancement of factor IXa.
  • Genetic analysis of Factor VIII variants associated with bleeding disorders.

Main Results:

  • Factor VIII comprises distinct functional domains (A1-A2-B-A3-C1-C2).
  • Processing yields heavy and light chains linked by metal ions, essential for activity.
  • Factor VIII significantly boosts factor IXa's ability to activate factor X.
  • Mutations in Factor VIII are frequently linked to severe hemorrhagic conditions.

Conclusions:

  • Factor VIII is a vital protein for effective blood coagulation.
  • Its structural integrity and processing are critical for hemostasis.
  • Understanding Factor VIII function and its variants is key for managing bleeding disorders.